We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Score from Single Plasma Sample Predicts Cardiovascular Disease

By LabMedica International staff writers
Posted on 23 Aug 2023
Print article
Image: Researchers used AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (Photo courtesy of Freepik)
Image: Researchers used AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (Photo courtesy of Freepik)

In a large retrospective analysis, utilizing measurements of plasma proteins from thousands of individuals across primary and secondary event populations, researchers have harnessed artificial intelligence (AI) to create a protein score for predicting major atherosclerotic cardiovascular disease events (ASCVD).

The study by scientists from deCODE genetics (Reykjavik, Iceland) was based on an extensive dataset comprising more than 13,500 Icelanders without a history of major ASCVD prior to plasma sampling, as well as over 6,000 participants from the FOURIER trial who had already experienced ASCVD before plasma sampling. In all these cases, plasma protein levels were assessed using the SomaScan platform, measuring approximately 5,000 plasma proteins. Notably, the protein risk score, derived solely from proteomics data of a single plasma sample, effectively predicts ASCVD events even without access to medical history or risk factor information. While much of the risk assessed by the proteins is also reflected in established risk factors, the protein score captures additional risk.

Furthermore, the protein risk score is a dynamic measure. Unlike certain immutable classic risk factors like family history and prior ASCVD events, this score can be modified upon treatment. The dynamic nature of protein risk scores—where protein levels fluctuate in relation to the timing of events—makes them well-suited for predicting event timelines. Consequently, these protein risk scores could prove invaluable in clinical trials for early evaluation of treatment efficacy or risk monitoring.

“We believe that in the proteomic risk score, we may have a biomarker that will allow the world to conduct shorter clinical trials with fewer participants,” said Kari Stefansson, CEO of deCODE genetics and one of the senior investigators of the study. “This is going to make the development of new medicines less expensive and make them available sooner for those who need them. Furthermore, in clinical practice it may allow for more effective prevention of ASCVD.”

Related Links:
deCODE genetics 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Hematology

view channel
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more

Pathology

view channel
Image: High-speed brightfield scanners offer excellent image quality to aid pathologists\' review of digital slides (Photo courtesy of Roche)

Whole-Slide Imaging System Enables Pathologists to Diagnose Patients Using Digital Images

Digital pathology involves the digitalization of the traditional pathology workflow, starting from slide scanning to visualization, to analysis. Digital pathology is transforming traditional histopathology... Read more

Industry

view channel
Image: The global urinalysis market is projected to grow at a CAGR of 9.6% to USD 6.8 billion by 2029 (Photo courtesy of Shutterstock)

Global Urinalysis Market Driven by Technological Advancements in POC Testing

Urinalysis is a practical and efficient technique for analyzing urine samples to detect various infections and chronic diseases such as diabetes, urinary tract infections, and kidney disease.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.